In brief
Prepatellar bursitis (housemaid's knee) is inflammation of the serous bursa lying between the skin and the anterior surface of the patella, triggered by repeated microtrauma (kneeling), a direct blow, infection or a systemic disease. It presents as a well-defined fluctuant swelling in front of the patella, with knee mobility typically preserved. The critical distinction sets the aseptic form (two thirds of cases) against the septic form (one third, an emergency dominated by Staphylococcus aureus). First-line treatment is conservative: PRICE, avoidance of kneeling, NSAIDs and the wearing of knee pads. The minimum annual incidence is 10 per 100,000.
Evidence-based clinical synthesis: aseptic/septic differentiation, diagnostic approach, conservative treatment, endoscopic bursectomy and occupational prevention.
Clinical synthesis
- Prepatellar bursitis is inflammation of the serous bursa lying between the skin and the anterior surface of the patella, triggered by repeated microtrauma (kneeling), a direct blow, infectious inoculation or a systemic disease (gout, polyarthritis).
- Minimum incidence of 10/100,000 per year, with a marked male predominance (80%) between the ages of 40 and 60, mainly in occupations involving repeated kneeling (floor layers, plumbers, roofers, gardeners, mechanics) and in wrestlers.
- The most critical distinction from a clinical standpoint is between the aseptic form (mechanical/traumatic, 2/3 of cases) and the septic form (infectious, 1/3 of cases): the latter is a medical emergency, whose antibiotic therapy is a matter for the doctor.
- The most common pathogen in septic bursitis is Staphylococcus aureus (more than 80% of documented cases), via a skin entry point (scratch, wound, puncture).
- Diagnosis is essentially clinical: a well-defined fluctuant swelling in front of the patella, pain on direct palpation, knee mobility typically preserved (unlike intra-articular involvement).
- Aspiration of the bursal fluid remains the gold standard when the diagnosis is in doubt (suspected infection, gout or pseudogout). Systematic cytobacteriological analysis: Gram stain, culture, crystals, white cell count.
- Ultrasound is the first-line imaging: it distinguishes a fluid collection from chronic fibrous thickening and can guide the aspiration (Draghi 2015).
- First-line treatment is conservative: PRICE (Protection, Rest, Ice, Compression, Elevation), strict avoidance of kneeling, topical or oral NSAIDs, systematic wearing of protective knee pads.
- The corticosteroid injections are controversial in prepatellar bursitis because of the skin risk (atrophy, depigmentation) and the infection risk (in a bursa that is a priori not infected); they are to be reserved for resistant chronic aseptic forms (Brown 2022, Brinks 2010).
- The endoscopic bursectomy does no worse than open surgery, with no difference in recurrence or complications in the Brown 2022 review, and may be considered after 6 months of well-conducted conservative treatment or for recurrent septic bursitis.
- Rehabilitation after the acute phase aims to restore range of motion and to progressively strengthen the quadriceps/hamstrings, without direct pressure on the bursa.
- Prevention of recurrence rests on three pillars: patient education, ergonomic modification of tasks (stool, alternating positions), and systematic wearing of suitable knee pads, the best-validated preventive measure in workers at risk.
- Return to activity should be guided by functional criteria (zero pain on palpation, full pain-free range of motion, quadriceps strength > 90% of the healthy side) and not by an arbitrary timetable.
- Differential diagnoses to know: septic arthritis of the knee (emergency), gouty tophus (Kosmoliaptsis 2007), tuberculosis of the bursa or patella (MacLean 2013, rare but to be considered in resistant chronic forms), prepatellar Morel-Lavallée lesion.
- Red flags requiring urgent medical referral: extensive cellulitis, fever > 38.5 °C, sepsis, immunosuppression (diabetes, alcohol misuse), failure of antibiotic therapy at 48-72h, suspected adjacent septic arthritis.
Contents
- What are the fundamentals to know about prepatellar bursitis?
- How do you assess and diagnose prepatellar bursitis with certainty?
- Septic bursitis: how do you avoid missing it? (specialised section)
- Which treatment strategies are the most effective?
- How do you secure lasting recovery and prevent flares?
- What do published clinical cases teach us about prepatellar bursitis?
- How do you apply these recommendations concretely in your practice?
What are the fundamentals to know about prepatellar bursitis?
Prepatellar bursitis, popularly known as housemaid's knee (in French, “genou de servante”), carpet-layer's knee (“genou du carreleur”) or roofer's knee (“genou du couvreur”), is one of the superficial bursitides most frequently encountered in physiotherapy, primary care and emergency departments.¹ Understanding its anatomy, the populations at risk, its pathophysiological mechanisms and its natural course determines how effective management will be. 🦵
How is this condition defined, who does it affect and what are the risk factors?
Prepatellar bursitis is defined as inflammation of the prepatellar serous bursa, a sac-shaped synovial structure lying between the anterior surface of the patella and the overlying skin.¹⁻² This bursa provides gliding and mechanical protection for the soft tissues at the front of the knee during flexion-extension. The prepatellar bursa is the second most frequently affected bursa in the body, just after the olecranon bursa, and is the most commonly affected bursa around the knee.¹
Epidemiologically, the landmark literature review Baumbach 2014 (52 studies analysed) reports a minimum annual incidence of 10/100,000, with a clear male predominance (≈ 80% of cases) between the ages of 40 and 60.² These figures reflect an occupational way of life: prepatellar bursitis is emblematic of occupations involving prolonged kneeling. 🧰
📊 Distribution of the aetiologies of prepatellar bursitis
Synthesis of Baumbach 2014 and Brown 2022: the aseptic/septic distinction is the critical decision point
Estimates based on Baumbach 2014 (n=52 studies, ≈ 1/3 septic vs 2/3 non-septic) and Brown 2022 (systematic review, 10 studies, 702 patients).
The risk factors for prepatellar bursitis fall into four broad categories:
- Repeated microtrauma (the dominant cause): prolonged, repetitive kneeling on hard surfaces. The most exposed occupations are floor and tile layers, plumbers, roofers, gardeners, miners and car mechanics.¹⁻³
- Direct trauma: a blow or a direct fall onto the patella can trigger acute haemorrhagic bursitis (sometimes bilateral and massive after repeated falls, as in the 2024 Cureus case report of a 60-year-old painter and decorator).⁴ A common mechanism in wrestlers: the landmark Mysnyk 1986 series of 136 college wrestlers found prepatellar bursitis to be the knee injury most frequently seen (21% of all initial knee injuries), with numerous recurrences.⁵
- Infection (septic bursitis): a break in the skin (scratch, wound, insect bite, abrasion) over the bursa allows direct bacterial inoculation. Septic bursitis accounts for about 1/3 of the cases reported.²٬⁶ Staphylococcus aureus is responsible for more than 80% of documented superficial septic bursitis cases.⁶٬⁷ See the dedicated section below.
- Underlying medical conditions: gout (prepatellar tophus mimicking chronic bursitis, Kosmoliaptsis 2007), rheumatoid arthritis, diabetes, immunosuppression, chronic kidney disease. The recent population-based study (n = 10,301 cases vs 44,608 controls) on olecranon bursitis, which can be extrapolated to the prepatellar bursa, confirms a link with hyperlipidaemia and certain cardiovascular comorbidities.⁸
⚠️ Occupations at risk of prepatellar bursitis: exposure gradient
Synthesis of Khodaee 2017, Rishor-Olney 2024 and Thun 1987: cumulative daily pressure on the prepatellar bursa
Note: floor and carpet layers make up less than 0.06% of the US workforce but file 6.2% of compensation claims for traumatic inflammation of the knee (Thun 1987). Bursitis was reported in 20% of them, compared with 6% of the millwrights and bricklayers used for comparison.
What happens in the bursa and how does the condition evolve naturally?
Pathophysiologically, repeated mechanical stimulation or acute trauma initiates an inflammatory response within the synovial membrane of the bursa.¹ Vasodilation, increased vascular permeability, leucocyte migration and the release of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) lead to synovial cell hyperplasia and increased production of synovial fluid (hence the characteristic fluctuant swelling).¹٬⁹
If the mechanical irritation persists, the bursitis progresses to a chronic stage, marked by fibrous thickening of the bursal walls, the possible formation of intrabursal rice bodies and reduced elasticity of the bursa. This fibrosis explains the tendency to recur under renewed loading and the poorer response to simple conservative treatments.²٬¹⁰ 🩺
The natural history depends radically on whether the bursitis is aseptic or septic:
- Acute aseptic bursitis: in the absence of new mechanical stress, spontaneous resolution is common within a few weeks. Without ergonomic modification, it progresses to chronicity with recurrent episodes.²٬¹⁰
- Chronic aseptic bursitis: palpable bursal thickening, persistent and only mildly painful swelling, moderate functional limitation. Poorer response to conservative treatment, potential indication for bursectomy (Brown 2022).¹¹
- Septic bursitis: UNFAVOURABLE natural course without antibiotic therapy. Risks: extensive cellulitis, septic arthritis of the knee by contiguous spread, patellar osteomyelitis, bacteraemia/sepsis, endocarditis (see the clinical case Journey From Knee to Heart, Qadeer 2023).⁷٬¹²
Key points
- Prepatellar bursitis is inflammation of the bursa lying between the skin and the patella, mainly caused by repeated pressure (occupational kneeling) or by direct trauma.
- Epidemiology: minimum incidence of 10/100,000 per year, men aged 40-60 (≈ 80%), exposed occupations (floor layers, plumbers, roofers, wrestlers).
- The aetiological distinction is fundamental: aseptic (mechanical/traumatic, 2/3 of cases) vs septic (≈ 1/3 of cases, a medical emergency dominated by S. aureus > 80%).
- Pathophysiology: synovial inflammation → fluid overproduction → chronic fibrous thickening if loading persists.
- Natural course favourable for the aseptic form (if the irritation stops), serious for the septic form without antibiotic therapy (cellulitis, septic arthritis, sepsis).
Bibliography
- Rishor-Olney CR, Taqi M, Pozun A. Prepatellar Bursitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. NBK557508. PMID 32491440.
- Baumbach SF, Lobo CM, Badyine I, Mutschler W, Kanz KG. Prepatellar and olecranon bursitis: literature review and development of a treatment algorithm. Arch Orthop Trauma Surg. 2014;134(3):359-370. PMID 24305696. doi:10.1007/s00402-013-1882-7.
- Khodaee M. Common Superficial Bursitis. Am Fam Physician. 2017;95(4):224-231. PMID 28290630.
- Maguire A, Lawrence C, Nicolai P, Rosenbloom C. Massive Bilateral Haemorrhagic Prepatellar Bursitis: A Case Report. Cureus. 2024;16(11):e74351. PMC 11668264. PMID 39720372.
- Mysnyk MC, Wroble RR, Foster DT, Albright JP. Prepatellar bursitis in wrestlers. Am J Sports Med. 1986;14(1):46-54. doi:10.1177/036354658601400109.
- Lormeau C, Cormier G, Sigaux J, Arvieux C, Semerano L. Management of septic bursitis. Joint Bone Spine. 2019;86(5):583-588. PMID 31615686.
- Qadeer H, Suwal A, Oke I. The Journey From Knee to Heart: A Case of Methicillin-Sensitive Staphylococcus aureus Infective Endocarditis Secondary to Septic Prepatellar Bursitis. Cureus. 2023;15(3):e36806. PMC 10146384.
- Shemesh S, Itzikovitch R, Atzmon R, et al. Risk Factors for the Development of Olecranon Bursitis-A Large-Scale Population-Based Study. J Clin Med. 2024;13(24):7801. PMID 39768728. PMC 11728362.
- Aaron DL, Patel A, Kayiaros S, Calfee R. Four common types of bursitis: diagnosis and management. J Am Acad Orthop Surg. 2011;19(6):359-367. PMID 21628647.
- Wilson-MacDonald J. Management and outcome of infective prepatellar bursitis. Postgrad Med J. 1987;63(744):851-853. PMID 3447109.
- Brown OS, Smith TO, Parsons T, Benjamin M, Hing CB. Management of septic and aseptic prepatellar bursitis: a systematic review. Arch Orthop Trauma Surg. 2022;142(10):2445-2457. PMID 33721054. doi:10.1007/s00402-021-03853-9.
- Truong J, Mabrouk A, Ashurst JV. Septic Bursitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. NBK470331.
How do you assess and diagnose prepatellar bursitis with certainty?

MRISagittal knee MRI: fluid collection distending the prepatellar bursa, arrows on the bursa.
Source : Telischak et al., The Indian journal of radiology & imaging, 2014, figure 5 · CC BY-NC-SA
The diagnosis of prepatellar bursitis is essentially clinical.¹ The aim is not only to confirm inflammation of the bursa, but above all to rule out the diagnoses that would radically change management, chief among them septic bursitis, a medical emergency, and septic arthritis of the knee, a surgical emergency.² 🩺
Which questions should you ask to understand the patient and their history?
History-taking is the first decisive step. It must be systematic and focused:
- Triggering mechanism: direct trauma (fall, blow)? Occupational or leisure activity involving prolonged/repetitive kneeling (tiling, plumbing, gardening, mechanics)? This distinction points towards an acute origin or a chronic origin from microtrauma.¹٬²
- Symptom history: first episode or recurrence? Time to onset (acute over a few hours to days suggests a traumatic or septic cause; insidious over weeks suggests a chronic mechanical cause)? Course under any empirical treatment.²
- Pain characteristics: strictly anterior patellar location, pain typical on direct pressure (kneeling) or at maximal knee flexion (stretching of the skin over the inflamed bursa). Conversely, walking on flat ground is generally well tolerated.¹٬³
- Systemic signs (CRITICAL): fever > 38 °C, chills, general malaise? ⚠️ Important: fever is inconsistent in septic bursitis (present in only 40-60% of patients depending on the series).⁴٬⁵ Its absence does not rule out infection.
- Skin entry point: systematic search for a wound, abrasion, insect bite or chronic skin lesion (eczema, psoriasis), over the bursa or at a distance.⁴
- Comorbidities carrying an infection risk: diabetes, chronic alcohol misuse, corticosteroid therapy, immunosuppressants, renal failure, active malignancy.⁵
- Inflammatory history: gout (previous attack, known tophus, hyperuricaemia), rheumatoid arthritis, other inflammatory rheumatic diseases.⁶
Which clinical tests should you perform and which other conditions must be ruled out?
The physical examination should be comparative (contralateral side) and focus on inspection, palpation and assessment of mobility, while keeping the differential diagnoses in mind.
Inspection: swelling usually well defined, round or oval, directly in front of the patella.¹ Look for erythema (redness), local warmth and a skin lesion acting as an entry point. Extensive redness spreading well beyond the bursa, or lymphangitis, strongly suggests septic bursitis with associated cellulitis.⁵
Palpation: confirms the fluctuant nature of the swelling (fluid collection) and exquisite tenderness on direct pressure.¹ Assess local warmth in comparison with the other side. Assess tenderness of the adjacent structures (patellar tendon, inferior pole of the patella, tibial tuberosity, Hoffa's fat pad).
Joint mobility (KEY DIFFERENTIAL DIAGNOSIS TEST):- In prepatellar bursitis that is uncomplicated, active knee range of motion is completely preserved or only painfully limited at maximal flexion (skin tension over the bursa).¹
- Conversely, marked painful limitation throughout the range, with inability to bear weight or major loss of function, suggests intra-articular pathology: septic arthritis of the knee (surgical emergency), acute flare of chondrocalcinosis, haemarthrosis.⁷
🩺 Comparative examination: prepatellar bursitis vs septic arthritis of the knee
Distinguishing these two entities is crucial: septic arthritis is a surgical emergency
| Criterion | Prepatellar bursitis | Septic arthritis of the knee |
|---|---|---|
| Location of the swelling | Strictly anterior, prepatellar, well defined | Diffuse around the knee, patellar tap + |
| Range of motion | Preserved or limited only in max flexion | Major limitation throughout the range |
| Weight-bearing / walking | Tolerated (normal walking on flat ground) | Unable to bear weight, loss of function |
| Intra-articular effusion | Absent | Present (patellar tap +, ballottement sign) |
| Aspiration | Prepatellar bursa | Joint (knee in 20° flexion) |
| Emergency | Medical (if septic) | Surgical (urgent joint lavage) |
Sources: Rishor-Olney 2024, Mathews 2007 (Ann Rheum Dis; SR on septic arthritis). If doubt persists, ultrasound-guided aspiration of both compartments (bursa + joint) is recommended.
The differential diagnosis must systematically rule out:
- Septic bursitis (see the dedicated section below): absolute priority.⁴٬⁵
- Septic arthritis of the knee: diffuse pain, major limitation, intra-articular effusion.⁷
- Gout / pseudogout (chondrocalcinosis): an inflammatory attack that can mimic septic bursitis. Looking for crystals under polarised light microscopy in the aspirated fluid = reference diagnostic test.⁶
- Patellar or quadriceps tendinopathy: pain over the tendon, reproduced by resisted contraction, with no bursal collection.
- Prepatellar Morel-Lavallée haematoma: post-traumatic separation of the cutaneous/subcutaneous planes, which can mimic chronic haemorrhagic bursitis.⁸
- Osgood-Schlatter disease (adolescents): pain over the anterior tibial tuberosity, not over the patella.
- Gouty tophus and bursal tuberculosis (rare): to be considered in resistant chronic forms (see the Kosmoliaptsis 2007 and MacLean 2013 cases).⁹٬¹⁰
Imaging is generally not needed to confirm the diagnosis of simple prepatellar bursitis.¹ Ultrasound is the first-line examination when in doubt: it confirms the fluid collection, measures bursal thickening, looks for rice bodies and makes it possible to guide the aspiration safely.¹¹٬¹² The sensitivity of ultrasound for detecting knee bursitis is around 87%, with a specificity of 100% (Draghi 2015). MRI is reserved for complex cases or for when an associated condition is suspected (patellar osteomyelitis, fracture, malignancy).¹³ 🔬
🚩 Red flags in the presence of prepatellar swelling
- Extensive cellulitis spreading well beyond the bursa + ascending lymphangitis
- Fever > 38.5 °C, chills, sepsis (tachycardia, hypotension)
- Major limitation of knee mobility with loss of function → suspected adjacent septic arthritis
- Immunosuppression: poorly controlled diabetes, alcohol misuse, corticosteroid therapy, immunosuppressants, malignancy
- Failure or worsening on antibiotic therapy at 48-72 h → medical review (reassessment: atypical organism, surgical indication)
- Chronic non-healing wound or ulceration over the bursa → suspected deep infection, osteomyelitis
- Chronic form resistant to conservative care > 6 months → consider gout, tuberculosis, tumour (rare)
- Non-traumatic bilateral involvement + systemic signs → rheumatological work-up (rheumatoid arthritis, tophaceous gout)
⚠️ Any red flag → prompt medical referral (GP, emergency department, orthopaedic surgeon) BEFORE any active physiotherapy management.
Should patients with prepatellar bursitis be classified, and with what benefits?
Yes: classification has a direct impact on treatment strategy. It is built around two axes: aetiology and timing.²
1. Aetiological classification:- Aseptic mechanical/traumatic (the dominant type, ≈ 65%): repeated microtrauma or a direct blow. Conservative treatment (PRICE, NSAIDs, knee pads, activity modification).¹٬²
- Septic infectious (≈ 33%): medical emergency, antibiotic therapy decided by the doctor + aspiration ± surgical drainage.⁴٬⁵
- Inflammatory/crystal-induced (rare, ≈ 2%): gout, rheumatoid arthritis, chondrocalcinosis. Treatment of the underlying condition + local management.⁶٬⁹
- Acute (< 6 weeks): rapid onset, marked inflammatory signs, often post-traumatic or septic.
- Chronic (> 6 weeks): repeated loading, thickened/fibrous bursal wall, persistent and less painful swelling. Poorer response to conservative treatment → potential indication for a selective corticosteroid injection (under strict conditions) or bursectomy.²٬¹¹
The main benefit of this dual classification is to structure a clear decision tree (see the septic bursitis section). It avoids over-medicalising simple forms and speeds up the management of emergencies.²

MRISagittal (A) and axial (B) knee MRI, fat-saturated T2 sequences: prepatellar bursa distended by an effusion, arrows on the collection.
Source : Chatra, The Indian journal of radiology & imaging, 2012, figure 1 · CC BY-NC-SA
Key points
- The diagnosis is essentially clinical: targeted history-taking + comparative examination (inspection / palpation / mobility).
- Absolute priority: distinguish aseptic from septic. Fever is inconsistent (40-60%); extensive erythema and cellulitis are more discriminating.
- Key test: knee mobility is preserved in bursitis (except at maximal flexion), and markedly limited in adjacent septic arthritis.
- Aspiration of the bursal fluid with analysis (Gram stain, culture, crystals, cytology) remains the gold standard when infection or gout is in doubt.
- Ultrasound (sensitivity ≈ 87%, specificity 100% for knee bursitis, Draghi 2015) is the first-line imaging and guides aspirations.
- Classifying (aetiology × timing) structures the treatment strategy and avoids over-medicalisation.
Bibliography
- Rishor-Olney CR, Taqi M, Pozun A. Prepatellar Bursitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. NBK557508.
- Baumbach SF, Lobo CM, Badyine I, Mutschler W, Kanz KG. Prepatellar and olecranon bursitis: literature review and development of a treatment algorithm. Arch Orthop Trauma Surg. 2014;134(3):359-370. PMID 24305696.
- Khodaee M. Common Superficial Bursitis. Am Fam Physician. 2017;95(4):224-231. PMID 28290630.
- Lormeau C, Cormier G, Sigaux J, Arvieux C, Semerano L. Management of septic bursitis. Joint Bone Spine. 2019;86(5):583-588. PMID 31615686.
- García-Porrúa C, González-Gay MA, Ibañez D, García-País MJ. The clinical spectrum of severe septic bursitis in northwestern Spain: a 10 year study. J Rheumatol. 1999;26(3):663-667. PMID 10090179.
- Truong J, Mabrouk A, Ashurst JV. Septic Bursitis. In: StatPearls. 2023. NBK470331.
- Mathews CJ, Kingsley G, Field M, et al. Management of septic arthritis: a systematic review. Ann Rheum Dis. 2007;66(4):440-445. PMID 17223664.
- Retal H, Cavez N, De Smet E, Abid W, Kadi R. Prepatellar Morel-Lavallée Effusion Mimicking a Bursitis. Cureus. 2024;16(4):e59129. PMC 11129518. PMID 38803733.
- Kosmoliaptsis V, Soni R. Tophaceous gout mass distending the prepatellar bursa. J Clin Rheumatol. 2007;13(6):359. PMID 18176150.
- MacLean S, Kulkarni S. Tuberculosis of the patella masquerading as prepatellar bursitis. Ann R Coll Surg Engl. 2013;95(1):e17-e19. PMC 3964674. PMID 23317718.
- Draghi F, Corti R, Urciuoli L, Alessandrino F, Rotondo A. Knee bursitis: a sonographic evaluation. J Ultrasound. 2015;18(3):251-257. PMC 4529416. PMID 26261475.
- Lueders DR, Smith J, Sellon JL. Ultrasound-Guided Knee Procedures. Phys Med Rehabil Clin N Am. 2016;27(3):631-648. PMID 27468670.
- Chatra PS. Bursae around the knee joints. Indian J Radiol Imaging. 2012;22(1):27-30. PMC 3354353.
Septic bursitis: how do you avoid missing it? (Specialised section) 🚨
The septic form of bursitis is defined as a bacterial infection (rarely fungal or tuberculous) of the bursa. It accounts for about 1/3 of prepatellar and superficial bursitis cases in general (Baumbach 2014, Brown 2022).¹٬² Recognising it is crucial because its treatment differs radically: antibiotic therapy decided by the doctor + aspiration ± surgical drainage, not conservative physiotherapy.³ ⚠️
Criteria for discriminating septic from aseptic bursitis
The major clinical challenge is that no single sign is sensitive or specific enough to formally differentiate septic bursitis from highly inflammatory aseptic bursitis.³ The combination of findings guides the clinician:
🔬 Criteria discriminating septic from aseptic bursitis: variable sensitivity
Lormeau 2019 (narrative review), García-Porrúa 1999 (n=75), Truong StatPearls 2023
| Criterion | Septic (sensitivity) | Aseptic | Discriminating value |
|---|---|---|---|
| Skin erythema spreading beyond the bursa / cellulitis | Very common (> 80%) | Rare | High |
| Local warmth > 2 °C vs contralateral side | Present | Often present too | Moderate |
| Fever > 38 °C | Only 40-60% | Absent | Moderate (inconsistent) |
| Visible skin entry point | ≈ 50% of cases | Possible (traumatic) | Moderate |
| At-risk comorbidities (diabetes, immunosuppression) | Over-represented | Possible | Moderate |
| CRP > 50 mg/L, leucocytosis | Common but non-specific | Possible (highly inflammatory) | Moderate |
| Bursal fluid leucocytes > 2,000-5,000/mm³ | Suggestive | Rare | High |
| Gram stain + bacteria on microscopy | Diagnostic | Sterile | Diagnostic |
| Positive culture | GOLD STANDARD | Sterile | Diagnostic |
Source: Lormeau C et al. Joint Bone Spine 2019;86(5):583-588 (PMID 31615686). No single clinical criterion has a sensitivity > 80%, hence the importance of aspiration at the slightest doubt.
- Staphylococcus aureus > 80% (methicillin-sensitive in most cases, MRSA depending on local prevalence).¹٬³٬⁴
- Streptococcus sp. (β-haemolytic, groups A, B, G): 5-10%.³
- Gram-negative bacteria (rare; immunosuppressed patients, seawater divers).³
- Mycobacteria (tuberculosis, atypical mycobacteria): exceptional but to be considered in resistant chronic forms (MacLean 2013).⁵
Aspiration, antibiotic therapy and drainage
🔀 Decision tree: suspected septic prepatellar bursitis
Adapted from Lormeau 2019, Brown 2022 and Truong StatPearls 2023
Simplified tree. Local adaptation according to microbial ecology (MRSA prevalence) and institutional recommendations. The choice of drug, route and duration lies with the doctor (2023 French recommendations).
- Strict surgical asepsis, skin disinfection, sterile gloves.
- 18G or 20G needle, lateral approach avoiding the erythematous skin.
- Ultrasound guidance recommended for a small collection or when the anatomy is in doubt (Lueders 2016).⁶
- Systematically send for: Gram stain, aerobic/anaerobic culture, antibiogram, cytology (white cell count), crystal search.³
- If the tap is dry: do not rule out infection; repeat it if the course is unfavourable.
Antibiotic therapy: this is a matter for the doctor, who chooses the drug, the route and the duration according to severity, local ecology and the 2023 French recommendations; a severe form or sepsis requires hospitalisation. The physiotherapist refers promptly and raises the alarm in the event of failure or worsening at 48-72 h under treatment.¹³
⚠️ The duration of antibiotic therapy for septic forms has not been established by trials. In the Brown 2022 review, courses of less than 8 days and of 8 days or more did not differ for recurrence of prepatellar bursitis (2/17 vs 10/114), with numbers too small to draw conclusions;² a French multicentre cohort found more failures with courses of under 14 days.¹⁴
Surgical indications (bursectomy):- Failure of well-conducted antibiotic therapy (duration set by the doctor).
- Recurrent septic bursitis.
- Purulent collection that cannot be drained by aspiration.
- Cutaneous fistula formation.
- Refractory chronic aseptic bursitis (> 6 months of conservative care).¹٬²
The endoscopic approach has become the standard where it is available: in the Brown 2022 review, it does not differ from open surgery for recurrence or for complications; case series report a shorter hospital stay and an earlier return to activity (Huang 2011, Luk 2020).²٬⁸٬⁹
Key points
- Septic bursitis = 1/3 of prepatellar bursitis cases, a medical emergency. S. aureus > 80%.
- No single clinical sign is discriminating enough. Extensive cellulitis, fever and immunosuppression are the most suggestive findings, but their absence does not rule out infection.
- Bursal aspiration (Gram stain, culture, crystals, cytology) is the diagnostic gold standard.
- Antibiotic therapy is a matter for the doctor (2023 French recommendations); failure or worsening at 48-72 h requires a medical opinion.
- Duration of antibiotic therapy: a medical decision, not established by any trial (Brown 2022, Charret 2021).
- Endoscopic bursectomy in the event of failure, recurrence or refractory chronic bursitis; no difference in complications compared with the open approach (Brown 2022).
Bibliography
- Baumbach SF, Lobo CM, Badyine I, Mutschler W, Kanz KG. Prepatellar and olecranon bursitis: literature review and development of a treatment algorithm. Arch Orthop Trauma Surg. 2014;134(3):359-370. PMID 24305696.
- Brown OS, Smith TO, Parsons T, Benjamin M, Hing CB. Management of septic and aseptic prepatellar bursitis: a systematic review. Arch Orthop Trauma Surg. 2022;142(10):2445-2457. PMID 33721054.
- Lormeau C, Cormier G, Sigaux J, Arvieux C, Semerano L. Management of septic bursitis. Joint Bone Spine. 2019;86(5):583-588. PMID 31615686.
- García-Porrúa C, González-Gay MA, Ibañez D, García-País MJ. The clinical spectrum of severe septic bursitis in northwestern Spain: a 10 year study. J Rheumatol. 1999;26(3):663-667. PMID 10090179.
- MacLean S, Kulkarni S. Tuberculosis of the patella masquerading as prepatellar bursitis. Ann R Coll Surg Engl. 2013;95(1):e17-e19. PMC 3964674. PMID 23317718.
- Lueders DR, Smith J, Sellon JL. Ultrasound-Guided Knee Procedures. Phys Med Rehabil Clin N Am. 2016;27(3):631-648. PMID 27468670.
- Mathews CJ, Kingsley G, Field M, et al. Management of septic arthritis: a systematic review. Ann Rheum Dis. 2007;66(4):440-445. PMID 17223664.
- Huang YC, Yeh WL. Endoscopic treatment of prepatellar bursitis. Int Orthop. 2011;35(3):355-358. PMID 20521045. doi:10.1007/s00264-010-1033-5.
- Luk WCB, Lui TH. Endoscopic Resection of Prepatellar Bursa. Arthrosc Tech. 2020;9(7):e1057-e1060. PMID 32714819.
- Reilly D, Kamineni S. Olecranon bursitis. J Shoulder Elbow Surg. 2016;25(1):158-167. PMID 26577126.
- Nchinda NN, Wolf JM. Clinical Management of Olecranon Bursitis: A Review. J Hand Surg Am. 2021;46(6):501-506. PMID 33840568.
- Qadeer H, Suwal A, Oke I. The Journey From Knee to Heart: A Case of MSSA Infective Endocarditis Secondary to Septic Prepatellar Bursitis. Cureus. 2023;15(3):e36806. PMC 10146384.
- Darrieutort-Laffite C, Coiffier G, Aïm F, et al. 2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis. Joint Bone Spine. 2024;91(2):105664. PMID 37995861.
- Charret L, Bart G, Hoppe E, et al. Clinical characteristics and management of olecranon and prepatellar septic bursitis in a multicentre study. J Antimicrob Chemother. 2021;76(11):3029-3032. PMID 34293150.
What are the most effective treatment strategies for prepatellar bursitis?
Management of prepatellar bursitis rests on a continuum of interventions, from the least to the most invasive. It is guided by the aetiological classification (aseptic vs septic) and by chronicity. The absolute prerequisite is to have ruled out septic bursitis (see the previous section), because its management differs radically (urgent antibiotic therapy, not physiotherapy). 🦵
Where do you start? What is the hierarchy of interventions?
For aseptic bursitis, the hierarchy follows a stepwise pathway:
- First-line conservative treatment: the PRICE protocol (Protection, Rest, Ice, Compression, Elevation), strict avoidance of kneeling activities, oral or topical NSAIDs for the painful phase (on medical prescription). Systematic wearing of protective knee pads as soon as activity resumes.¹⁻³
- Bursal aspiration: can rapidly relieve pressure and pain. However, the recurrence rate is high if the underlying mechanical cause is not corrected. To be preferred when there is marked functional limitation or diagnostic doubt (cytobacteriological analysis).⁴
- Corticosteroid injection (controversial): an option for resistant chronic aseptic bursitis. Documented risks: skin atrophy, depigmentation, iatrogenic infection (in an initially aseptic bursa), a rare risk to tendons through diffusion.⁵٬⁶ Several recent reviews recommend caution and selectivity in this indication, because of the skin complications specific to the superficial prepatellar bursa.⁴
- Surgical bursectomy: a last resort for chronic, recurrent or refractory septic forms. Endoscopic approach recommended (Huang 2011, Luk 2020): no difference in recurrence or complications compared with the open approach (Brown 2022).⁴٬⁷٬⁸
📊 Treatment modalities for prepatellar bursitis: level of evidence (adapted GRADE)
Synthesis of Brown 2022 (SR n=702), Lormeau 2019 (narrative review) and Khodaee 2017: most recommendations rest on observational series and expert opinion
| Intervention | Aseptic form | Septic form | Level of evidence (GRADE) |
|---|---|---|---|
| PRICE + avoidance + knee pads | First line | Adjunct | Moderate (expert opinion, plausibility) |
| Oral or topical NSAIDs | First line (short term) | Symptomatic | Moderate (transposed from other bursitides) |
| Diagnostic + therapeutic aspiration | Marked limitation or doubt | Essential (Gram stain/culture) | High (diagnostic gold standard) |
| Antibiotic therapy (septic form) | - | Essential | Medical decision (2023 French recommendations, expert opinion) |
| Intrabursal corticosteroid injection | Selected chronic form | CONTRAINDICATED | Low (controversial, skin risks) |
| Endoscopic bursectomy | Conservative failure > 6 months | Recurrent / refractory | Moderate (Brown 2022, comparative series) |
| Open bursectomy | If endoscopy is unavailable | Complex cases / fistula | Moderate (no difference in complications from endoscopy, Brown 2022) |
| Local manual therapy | Adjunct in the post-acute phase | - | Very low (extrapolation) |
| Ultrasound / laser / TENS | Not recommended routinely | - | Very low (no specific benefit demonstrated) |
| Shock waves (ESWT) | No specific evidence | - | Very low (evidence in other tendinopathies, Mani-Babu 2015) |
| Patient education + ergonomics + recurrence prevention | First line (always) | Essential after an episode | Moderate (plausibility, mechanism) |
Grading: High = international consensus, robust data; Moderate = SR or converging cohorts; Low = controversial or limited data; Very low = extrapolation, expert opinion.
What is the place of exercise in rehabilitation?
💡 There are no randomised controlled trials defining a superior exercise protocol for prepatellar bursitis. The approach relies on general physiological principles and on extrapolation from protocols validated in other knee conditions (knee osteoarthritis, patellar tendinopathy).
Acute phase (days 0-10):
- NO direct strengthening or aggressive stretching of the prepatellar region.
- Goal: “calm things down”, reduce inflammation, avoid direct pressure.
- Gentle active knee mobilisation within pain-free limits to prevent stiffness.
Subacute phase (weeks 2-6):
- Recovery of full range of motion (passive then active flexion-extension).
- Isometric quadriceps strengthening (sets), then progression to closed-chain exercises (mini-squats, leg press) without prepatellar skin pressure.
- Gentle stretching of the quadriceps, hamstrings and triceps surae within pain-free limits.
Functional return phase (weeks 6+):
- Progressive open- and closed-chain strengthening.
- Gradual reintroduction of at-risk positions (kneeling) with a knee pad, in short sessions initially.
- Proprioceptive and movement-specific work according to occupational or sporting demands.
The approach is therefore individualised and symptom-guided, with no single scientifically validated protocol.
Manual therapies and technologies: how effective are they really?
The level of evidence for manual therapies and physical modalities (laser, ultrasound, TENS, shock waves) applied specifically to prepatellar bursitis is low to very low. Their use should remain selective and critical:
- Manual therapy (gentle peripatellar soft-tissue mobilisation): no robust evidence; it may be offered in the post-acute phase to improve local mobility. Avoid any manoeuvre that directly compresses the bursa.
- Cryotherapy (ice): the simplest and best-validated modality in the acute phase, for its analgesic effect.⁹
- Extracorporeal shock wave therapy (ESWT): favourable evidence in some lower-limb tendinopathies (Mani-Babu 2015) but no specific data on non-calcific aseptic prepatellar bursitis. Not recommended routinely.¹⁰
- Therapeutic ultrasound and low-level laser: no evidence of a significant specific benefit. Use not scientifically demonstrated for this indication.
- TENS: possibly as an adjunct analgesic, without altering the course of the condition.
Beyond the physical: how do you educate the patient about prevention?
🧘♂️ Therapeutic patient education (TPE) is probably the most important component of long-term management. It is essential for preventing recurrences, which are common in this occupational condition.¹
The pillars of education:
- Understanding the causal mechanism: the patient needs to know WHY their bursa became inflamed (repeated direct pressure) in order to adhere to the preventive measures.
- Ergonomic modification of activities: alternating positions, using a low stool, taking regular breaks to stand up and restore blood flow.²
- Systematic wearing of suitable protective knee pads (high-density foam, gel) during at-risk activities, the most empirically validated preventive measure.¹⁻³
- Progressive load management: recognising early signs of an inflammatory flare (swelling, warmth, pain) and adapting activities immediately.
- Addressing kinesiophobia in chronic forms: reassuring communication, explaining that progressive, pain-free movement is beneficial, is crucial to avoid deconditioning.¹¹
Critique and controversies: the grey areas of management
The literature on prepatellar bursitis suffers from a lack of high-quality randomised controlled trials, particularly on physiotherapy interventions. The Brown 2022 systematic review, the most rigorous to date, included only 10 studies and 702 patients for such a common topic.⁴ Many current recommendations rest on expert opinion and physiological extrapolation. This calls for great humility on the clinician's part.
Three specific controversies deserve attention:
1. Corticosteroid injections. They are widely used routinely for their rapid anti-inflammatory effect, but their benefit/risk balance is now being questioned. The iatrogenic risk of introducing infection into an aseptic bursa, and the skin atrophy and depigmentation specific to the thin prepatellar skin, have led several authors to reserve this option for very carefully selected chronic aseptic cases, after failure of a well-conducted conservative approach and after infection has been formally ruled out.⁵٬⁶
2. Endoscopic vs open approach. In the Brown 2022 review, endoscopic bursectomy does not differ from the open approach for recurrence or complications. However, availability of the technique varies widely, there is a learning curve, and cost-effectiveness across all health systems has not been formally demonstrated.⁴
3. Duration of antibiotic therapy for septic forms. It has not been established by any trial and is a matter for the doctor: Brown 2022 found no more recurrence with under 8 days (2/17 vs 10/114), with numbers too small to draw conclusions,⁴ and a French multicentre cohort found more failures with under 14 days.¹²
Key points
- Absolute priority: differentiate aseptic vs septic. The latter is a medical emergency.
- First-line treatment for aseptic forms: conservative (PRICE + avoidance of kneeling + knee pads + NSAIDs).
- Exercise is introduced after the acute phase, focusing on recovering range of motion and on progressive strengthening without direct pressure on the bursa.
- Patient education on ergonomics and on the systematic wearing of knee pads is the cornerstone of recurrence prevention.
- ⚠️ The corticosteroid injections are controversial: skin and infection risks specific to the prepatellar skin; selective use after conservative failure.
- ❌ The evidence supporting the effectiveness of manual therapies or of most technologies (ultrasound, laser, ESWT) for prepatellar bursitis is very weak.
- 🔪 The endoscopic bursectomy is the recommended surgical approach in the event of conservative failure or refractory septic bursitis (Brown 2022).
Bibliography
- Rishor-Olney CR, Taqi M, Pozun A. Prepatellar Bursitis. StatPearls. 2024. NBK557508.
- Khodaee M. Common Superficial Bursitis. Am Fam Physician. 2017;95(4):224-231. PMID 28290630.
- Aaron DL, Patel A, Kayiaros S, Calfee R. Four common types of bursitis: diagnosis and management. J Am Acad Orthop Surg. 2011;19(6):359-367. PMID 21628647.
- Brown OS, Smith TO, Parsons T, Benjamin M, Hing CB. Management of septic and aseptic prepatellar bursitis: a systematic review. Arch Orthop Trauma Surg. 2022;142(10):2445-2457. PMID 33721054.
- Brinks A, Koes BW, Volkers AC, Verhaar JA, Bierma-Zeinstra SM. Adverse effects of extra-articular corticosteroid injections: a systematic review. BMC Musculoskelet Disord. 2010;11:206. PMC 2945953.
- Chatra PS. Bursae around the knee joints. Indian J Radiol Imaging. 2012;22(1):27-30. PMC 3354353.
- Huang YC, Yeh WL. Endoscopic treatment of prepatellar bursitis. Int Orthop. 2011;35(3):355-358. PMID 20521045.
- Luk WCB, Lui TH. Endoscopic Resection of Prepatellar Bursa. Arthrosc Tech. 2020;9(7):e1057-e1060. PMID 32714819.
- Malanga GA, Yan N, Stark J. Mechanisms and efficacy of heat and cold therapies for musculoskeletal injury. Postgrad Med. 2015;127(1):57-65. PMID 25526231.
- Mani-Babu S, Morrissey D, Waugh C, Screen H, Barton C. The effectiveness of extracorporeal shock wave therapy in lower limb tendinopathy: a systematic review. Am J Sports Med. 2015;43(3):752-761. PMID 24817008.
- Wertli MM, Rasmussen-Barr E, Weiser S, Bachmann LM, Brunner F. The role of fear avoidance beliefs as a prognostic factor for outcome in nonspecific low back pain: a systematic review. Spine J. 2014;14(5):816-836. PMID 24412032.
- Charret L, Bart G, Hoppe E, et al. Clinical characteristics and management of olecranon and prepatellar septic bursitis in a multicentre study. J Antimicrob Chemother. 2021;76(11):3029-3032. PMID 34293150.
How do you secure lasting recovery and prevent flares?
Preventing recurrence is a central goal: chronic forms are disabling, sometimes resistant to conservative treatment, and in some cases require bursectomy.¹ A proactive approach centred on education and lasting behaviour change is more effective than simply managing symptoms over and over.²
How do you make the patient an active participant in their recovery?
🧑🏫 Empowering the patient is the most lasting strategy for preventing recurrence. It rests on four pillars:
1. Understanding the causal mechanism: the patient must make an explicit link between a specific action (unprotected kneeling, direct blow) and the resulting pain. This awareness is the driver of behaviour change.³
2. Activity modification:- Favour alternative positions: low stool, brief squatting.
- Break up kneeling tasks (5-10 min, then a standing break).
- Adapt the workstation if possible (raised tiling board, plumbing table).
- Wearing suitable knee pads systematically (good quality: high-density foam, gel, rigid shell depending on the trade).
- Check the condition of the knee pad regularly (wear, compressed foam).
- Choose comfortable models to encourage adherence: uncomfortable equipment will not be worn.
- Recognise early signs of irritation: morning swelling, local warmth, residual pain after activity.
- Adapt immediately (reduce activity for 24-48h, ice, topical NSAID).
- Reintroduce gradually, never abruptly.
When and how do you plan a safe return to activity?
The return to occupational or sporting activity should be a structured, criteria-based process, not one based on an arbitrary timeframe. 📅 A premature return is a major risk factor for recurrence or progression to chronicity.
Essential criteria before a full return:
- Complete resolution of symptoms: no pain on direct palpation of the bursa, nor during knee movements or basic functional activities. Disappearance of any residual effusion.
- Range of motion restored: full flexion and extension, symmetrical with the contralateral side, pain-free.
- Normalised muscle strength: quadriceps and hamstring strength ≥ 90-95% of the healthy limb (isokinetic test or a functional pivot test such as the single-leg hop).
- Job/sport-specific functional tests: ability to kneel (on a knee pad), get up, pivot, jump and climb stairs without pain or apprehension.
- Psychological confidence: assessment of kinesiophobia (fear of movement, fear of recurrence). A high score on the Tampa Scale for Kinesiophobia should prompt the integration of cognitive-behavioural strategies.⁴
The return should follow a progressive plan:
- Tiler: short days initially (3-4h), high-quality knee pads, frequent breaks, return to full time within 2-4 weeks depending on progress.
- Wrestler: first a return to non-contact technical exercises (drills), then controlled bouts on the mat with a knee pad, then competition.
- Gardener: alternate standing, squatting and protected kneeling positions; avoid long sessions on hard paving.
Critique and controversies: the difficulty of evaluating prevention
The literature sorely lacks studies with a high level of evidence (randomised controlled trials, systematic reviews) specifically dedicated to preventing recurrence of prepatellar bursitis. Most current recommendations are extrapolated from the management of other overuse conditions or based on pathophysiological reasoning and consensus.¹
One persistent controversy: adherence to wearing knee pads in the real world of work. Productivity constraints, the perceived discomfort of some models and the lack of a preventive culture in some sectors (construction in particular) hinder systematic adoption. Structured company ergonomics programmes are needed but are poorly documented scientifically.²
Key points
- ✅ Preventing recurrence rests on patient education and lasting modification of at-risk activities.
- 🛡️ The systematic use of protective knee pads suited to the task is the most important preventive measure for occupations involving kneeling.
- 📈 Return to activity should be progressive and guided by functional criteria (zero pain, full range of motion, strength ≥ 90%, functional tests) and not by an arbitrary timetable.
- 🧠 Patient empowerment through structured self-management strategies is the key to long-term success.
- ⚠️ Adherence to wearing protection remains a challenge in the workplace; a company ergonomics programme strengthens individual adherence.
Bibliography
- Khodaee M. Common Superficial Bursitis. Am Fam Physician. 2017;95(4):224-231. PMID 28290630.
- Aaron DL, Patel A, Kayiaros S, Calfee R. Four common types of bursitis: diagnosis and management. J Am Acad Orthop Surg. 2011;19(6):359-367. PMID 21628647.
- Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):191-215. PMID 847061.
- Wertli MM, Rasmussen-Barr E, Weiser S, Bachmann LM, Brunner F. The role of fear avoidance beliefs as a prognostic factor for outcome in nonspecific low back pain: a systematic review. Spine J. 2014;14(5):816-836. PMID 24412032.
- Brown OS, Smith TO, Parsons T, Benjamin M, Hing CB. Management of septic and aseptic prepatellar bursitis: a systematic review. Arch Orthop Trauma Surg. 2022;142(10):2445-2457. PMID 33721054.
- Hoffmann TC, Montori VM, Del Mar C. The connection between evidence-based medicine and shared decision making. JAMA. 2014;312(13):1295-1296. PMID 25268434.
- Cook JL, Rio E, Purdam CR, Docking SI. Revisiting the continuum model of tendon pathology: what is its merit in clinical practice and research? Br J Sports Med. 2016;50(19):1187-1191. PMID 27127294.
What do published clinical cases teach us about prepatellar bursitis? 📚
Prepatellar bursitis is often perceived as a “simple” condition, but analysis of published clinical cases reveals diagnostic subtleties and serious complications that deserve the clinician's attention. 👨🔧
Analysis of a typical case: from diagnosis to resolution
The typical case is that of a middle-aged man in an occupation involving kneeling, presenting with a well-defined fluctuant swelling at the front of the knee, without systemic signs. The clinical diagnosis is made; ultrasound confirms the fluid collection and excludes chronic fibrous thickening. Management combines avoidance of kneeling, application of ice, a short course of NSAIDs, wearing knee pads and therapeutic education. Complete resolution of symptoms is observed within 4 to 6 weeks in the majority of uncomplicated cases.¹
⚠️ Important, methodological note: many reviews cite “typical” patient profiles (precise age, occupation, duration of symptoms) without always referencing a single publication. These teaching syntheses (which are not intended to be real clinical cases) must be distinguished from the published, indexed case reports, presented below.
The diagnostic challenge: when bursitis mimics another condition
Case 1: massive bilateral chronic bursitis (Maguire 2024, Cureus, PMC 11668264)A 60-year-old man, a painter and decorator, presenting with bilateral anterior swelling of both knees that had been developing for 6 years following an initial fall onto both knees.² The swellings were large enough to interfere with wearing trousers and with leaning against a ladder. Surgical management consisted of sequential excision of the bursae: on the right, organised solid contents (chronic haematoma resembling “chocolate paste”); on the left, thick brown fluid drained in addition to the fibrous tissue. Follow-up of more than 2 years: no recurrence.
Lesson: massive bilateral chronic bursitis is rare but can occur in a context of repeated occupational microtrauma. The “solid” form (organised fibrous haematoma) rules out simple drainage and requires bursectomy. An open approach was chosen here because of the size of the lesion; in routine practice, endoscopy remains preferred for moderately sized bursitis.
Case 2: gouty tophus mimicking chronic bursitis (Kosmoliaptsis 2007, PMID 18176150)A patient with a firm, chronic prepatellar mass, initially labelled as fibrous bursitis. Imaging showed a heterogeneous signal. Histological analysis after excision revealed a gouty tophus (birefringent needle-shaped monosodium urate crystals), an unexpected diagnosis that justified long-term urate-lowering treatment.³
Lesson: in patients with a history of gout (hyperuricaemia, attacks of podagra), a prepatellar mass should raise the possibility of a tophus among the differential diagnoses. Cytological analysis of the fluid or tissue (looking for birefringent crystals under polarised light microscopy) is diagnostic. Rheumatoid arthritis can also cause chronic inflammation of the prepatellar bursa.
Case 3: patellar tuberculosis mimicking prepatellar bursitis (MacLean 2013, PMC 3964674)A 25-year-old woman of Bangladeshi origin, with insidious swelling of the right knee for 3 months following a fall. Initial treatment with oral flucloxacillin, without improvement. X-ray: central necrotic nidus in the patella. MRI: osteomyelitis confirmed. Microbiology of the bone sequestrum: Mycobacterium tuberculosis (acid-fast bacilli on culture). Prolonged antituberculous treatment.⁴
Lesson: in an at-risk population (origin from an endemic area, immunosuppression, history of pulmonary TB), chronic bursitis that does not respond to standard antibiotic therapy should raise the possibility of tuberculosis. The index of suspicion must be high because the disease is paucibacillary and the initial signs are non-specific.
Study of a complex case: septicaemia and endocarditis arising from bursitis
Case 4: MSSA endocarditis secondary to septic prepatellar bursitis (Qadeer 2023, Cureus, PMC 10146384)A patient with a history of recurrent prepatellar bursitis that had required several catheter drainages. Presented to the emergency department with sepsis and infective endocarditis. Blood cultures: Staphylococcus aureus (methicillin-sensitive, MSSA). Echocardiography: valvular vegetations. The identified source was poorly controlled prepatellar bursitis. Treatment: prolonged IV antibiotic therapy + cardiological management.⁵ 💔
Lesson: although rare, endocarditis secondary to poorly treated septic bursitis illustrates the potential severity of neglected septic bursitis. The clinical message is clear: recurrent septic bursitis must be managed aggressively (surgical drainage if it recurs after aspiration, bursectomy in the event of failure), and systemic bacteraemia should always be sought in a septic patient with an obvious skin/bursal focus.
Case 5: bursitis treated by endoscopic bursectomy (Huang 2011, PMID 20521045)Prospective series of 60 patients (mean age 33.5 years) with traumatic prepatellar bursitis refractory to conservative treatment. Bursectomy performed endoscopically as day surgery under local anaesthesia, 2-3 arthroscopic mini-portals, mean duration 18 minutes. Mean follow-up of 36.3 months: all patients asymptomatic, normal knee function, no infection or loss of range of motion, no skin-related revision.⁶
Lesson: endoscopic bursectomy offers good functional results; the Brown 2022 systematic review (10 studies) finds no difference in complications from the open approach.⁷
Critique and controversies in the case literature
The case report literature on prepatellar bursitis remains fragmented. Several areas of debate persist:
1. The threshold for performing a diagnostic aspiration. Essential when infection is suspected. But performing it systematically for apparently aseptic bursitis is debated because of the iatrogenic risk of inoculation.⁸ The literature provides no clear consensus, leaving the decision to clinical judgement.
2. The place of corticosteroid injections. Effective in the short term but carrying skin and infection risks specific to the thin prepatellar skin. Several recent reviews recommend caution and reserving them for selected chronic aseptic cases, after infection has been formally ruled out.⁷٬⁹
3. Management of septic bursitis. Systematic hospitalisation vs outpatient care, duration of antibiotic therapy, early surgical indication vs surgery after failure: so many questions on which practices vary. Complex cases (such as the Qadeer 2023 endocarditis) argue for an aggressive approach in the event of non-response to the initial treatment.⁵٬¹⁰
⚠️ Level of evidence: a case report = level 5 (the lowest in the CEBM hierarchy). It illustrates, but never demonstrates efficacy or superiority. Where findings diverge, meta-analyses and systematic reviews (level 1a) must take precedence.
Key points
- ✅ The typical case of prepatellar bursitis (manual worker, fluctuant swelling, conservative treatment, resolution in 4-6 weeks) remains the most common.
- 🤔 Conditions such as gouty tophus (Kosmoliaptsis 2007) or patellar tuberculosis (MacLean 2013) can mimic chronic bursitis; consider them when the presentation is atypical or the condition resistant.
- ⚠️ The most dreaded complication is MSSA endocarditis secondary to neglected septic bursitis (Qadeer 2023, Cureus), hence the imperative of aggressive management in the event of non-response.
- 🔪 The endoscopic bursectomy performed as day surgery (Huang 2011, series n=60) offers excellent functional results with a very favourable complication profile.
- 📊 A case report = level 5: it illustrates but does not demonstrate. Meta-analyses (level 1a) take precedence in the event of conflict.
Bibliography
- Rishor-Olney CR, Taqi M, Pozun A. Prepatellar Bursitis. StatPearls. 2024. NBK557508.
- Maguire A, Lawrence C, Nicolai P, Rosenbloom C. Massive Bilateral Haemorrhagic Prepatellar Bursitis: A Case Report. Cureus. 2024;16(11):e74351. PMC 11668264. PMID 39720372.
- Kosmoliaptsis V, Soni R. Tophaceous gout mass distending the prepatellar bursa. J Clin Rheumatol. 2007;13(6):359. PMID 18176150.
- MacLean S, Kulkarni S. Tuberculosis of the patella masquerading as prepatellar bursitis. Ann R Coll Surg Engl. 2013;95(1):e17-e19. PMC 3964674. PMID 23317718.
- Qadeer H, Suwal A, Oke I. The Journey From Knee to Heart: A Case of Methicillin-Sensitive Staphylococcus aureus Infective Endocarditis Secondary to Septic Prepatellar Bursitis. Cureus. 2023;15(3):e36806. PMC 10146384.
- Huang YC, Yeh WL. Endoscopic treatment of prepatellar bursitis. Int Orthop. 2011;35(3):355-358. PMID 20521045.
- Brown OS, Smith TO, Parsons T, Benjamin M, Hing CB. Management of septic and aseptic prepatellar bursitis: a systematic review. Arch Orthop Trauma Surg. 2022;142(10):2445-2457. PMID 33721054.
- Lormeau C, Cormier G, Sigaux J, Arvieux C, Semerano L. Management of septic bursitis. Joint Bone Spine. 2019;86(5):583-588. PMID 31615686.
- Brinks A, Koes BW, Volkers AC, Verhaar JA, Bierma-Zeinstra SM. Adverse effects of extra-articular corticosteroid injections: a systematic review. BMC Musculoskelet Disord. 2010;11:206. PMC 2945953.
- García-Porrúa C, González-Gay MA, Ibañez D, García-País MJ. The clinical spectrum of severe septic bursitis in northwestern Spain: a 10 year study. J Rheumatol. 1999;26(3):663-667. PMID 10090179.
How do you apply these recommendations concretely in your practice?
Applying recommendations is the bridge between science and better care. It requires knowing what to do, when to collaborate, and how to measure the impact. This section provides a practical framework for prepatellar bursitis. 🧑⚕️
When should you refer, and to which professionals?
The core competence of the physiotherapist is to recognise the limits of their scope and to identify situations requiring interprofessional collaboration.
The identification of red flags (see the red-flag box in the Diagnosis chapter) is the first, non-negotiable step. An international framework was established by Finucane 2020 for spinal pathologies, and its methodological principles apply: red flags should be assessed cumulatively and within an overall clinical context, not as isolated items of low predictive value.¹
Referrals to consider in prepatellar bursitis:- Emergency department / urgent GP: suspected septic bursitis (extensive cellulitis, fever, sepsis, immunosuppression), suspected adjacent septic arthritis, uncontrolled infected skin wound.
- Orthopaedic surgeon / surgeon: chronic bursitis > 6 months resistant to conservative treatment, septic bursitis refractory to antibiotic therapy, suspected associated osteoarticular lesion, potential indication for bursectomy.
- Infectious disease specialist: atypical organisms (MRSA, tuberculosis, atypical mycobacteria), severe immunosuppression, failure of antibiotic therapy at 48-72 h.
- Rheumatologist: suspected systemic inflammatory disease (rheumatoid arthritis, tophaceous gout, chondrocalcinosis, spondyloarthritis).
- Occupational physician: recognition as an occupational disease (table 57 of the general social security scheme in France, section D, which covers acute hygroma of the knee, with a 7-day coverage period, and chronic hygroma of the knee, 90 days), workstation adjustment, collective prevention.
- Psychologist: marked yellow flags (kinesiophobia, catastrophising, anxiety about returning to work), psychosocial factors hindering recovery.²
The interprofessional collaboration is central in complex cases (multiple recurrences, comorbidities, disabling chronic cases). Clear communication and defined referral protocols avoid diagnostic delays and optimise the care pathway.³ Shared decision-making (SDM, Hoffmann 2014) is a powerful lever: presenting the patient with the options (prolonged conservative care, injection, bursectomy) together with their respective benefits and risks, and actively involving them in the choice.⁴
How do you measure outcomes and overcome barriers to implementation?
To evaluate the effectiveness of interventions, it is necessary to go beyond simply measuring range of motion. Patient-reported outcome measures (PROMs) capture the patient's perception of pain, function and quality of life.⁵
Relevant PROMs for prepatellar bursitis and the knee:
- KOOS (Knee injury and Osteoarthritis Outcome Score): 5 dimensions (pain, symptoms, ADL, sport, quality of life), broad functional coverage.
- IKDC (International Knee Documentation Committee): subjective knee function, validated in the general and sporting populations.
- NRS (Numeric Rating Scale) or pain VAS: simple, usable in a short consultation.
- Tampa Scale for Kinesiophobia (TSK-11): for chronic patients with a fear-of-movement component.
- EQ-5D: generic quality of life, for health-economic evaluation.
The adoption of a standardised Core Outcome Set (COS) for prepatellar bursitis is not yet established in the literature, but the principles of the generic COS-Knee can be applied.
Barriers to implementation and strategies to overcome them:
- Lack of time: use short PROMs and concise summaries of systematic reviews (Cochrane summaries, BMJ Best Practice).
- Lack of access to articles: make use of free resources (PubMed Central, institutional access).
- Lack of critical appraisal skills: targeted continuing education, mentoring, multidisciplinary journal clubs.
- Organisational culture: support from managers, allocation of dedicated time for continuing education.
- Patient adherence: co-construct the goals, simplify the advice, check understanding with open questions.
Critique and controversies: reflections on the challenges of implementation
🧠 Three tensions deserve critical reflection:
1. The red flag paradox. Essential for safety, red flags individually have a low positive predictive value.⁶٬⁷ Focusing on them excessively can lead to over-prescription of investigations and to iatrogenic anxiety. Clinical skill lies in the ability to assess the cumulative weight of the signs, not in reacting to a single item, and this reasoning is difficult to standardise.
2. The gap between research and practice. The literature on prepatellar bursitis illustrates the problem: 10 studies in the best available systematic review (Brown 2022) for such a common condition. Science needs to produce more pragmatic evidence (real-world trials, care registries, real-world data) that can be directly transferred to everyday clinical practice.⁸
3. Standardisation vs personalisation. Protocols and COS are necessary for quality and research, but the heart of physiotherapy is personalisation. Expert practice navigates between the two: using standardised tools for follow-up while designing treatment plans that respect the patient's unique goals (a 45-year-old tiler vs an elite athlete vs an older person living at home).
Key points
- Referral is crucial for safety: red flags (cellulitis, fever, immunosuppression, antibiotic failure) → prompt medical assessment; yellow flags → psychological collaboration.
- The interprofessional collaboration (GP, emergency physician, orthopaedic surgeon, infectious disease specialist, occupational physician) is essential for complex cases and for recognition as an occupational disease.
- Measure outcomes with knee-specific PROMs (KOOS, IKDC, NRS, TSK-11) and consider a Core Outcome Set to standardise follow-up.
- The barriers to evidence-based implementation (time, training, access) are real; multi-level strategies are needed (individual, organisational, systemic).
- The practice of shared decision-making (Hoffmann 2014) is a powerful lever for treatment adherence and recurrence prevention.
Bibliography
- Finucane LM, Downie A, Mercer C, et al. International Framework for Red Flags for Potential Serious Spinal Pathologies. J Orthop Sports Phys Ther. 2020;50(7):350-372. PMID 32438853. doi:10.2519/jospt.2020.9971.
- Wertli MM, Rasmussen-Barr E, Weiser S, Bachmann LM, Brunner F. The role of fear avoidance beliefs as a prognostic factor for outcome in nonspecific low back pain: a systematic review. Spine J. 2014;14(5):816-836. PMID 24412032.
- Kamper SJ, Apeldoorn AT, Chiarotto A, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015;350:h444. PMID 25694111.
- Hoffmann TC, Montori VM, Del Mar C. The connection between evidence-based medicine and shared decision making. JAMA. 2014;312(13):1295-1296. PMID 25268434.
- Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003;1:64. PMID 14613558.
- Verhagen AP, Downie A, Maher CG, Koes B. Most red flags for malignancy in low back pain guidelines lack empirical support: a systematic review. Pain. 2017;158(10):1860-1868. PMID 28708761.
- Henschke N, Maher CG, Ostelo RWJG, de Vet HCW, Macaskill P, Irwig L. Red flags to screen for malignancy in patients with low-back pain. Cochrane Database Syst Rev. 2013;(2):CD008686. PMID 23450586.
- Glasgow RE, Lichtenstein E, Marcus AC. Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health. 2003;93(8):1261-1267. PMID 12893608.
- Brown OS, Smith TO, Parsons T, Benjamin M, Hing CB. Management of septic and aseptic prepatellar bursitis: a systematic review. Arch Orthop Trauma Surg. 2022;142(10):2445-2457. PMID 33721054.
What next after reading this?
This article is part of a collection of evidence-based clinical syntheses. A question, some feedback, a correction to suggest? Contact us directly via the WhatsApp button at the bottom right of the screen.





















